How Can Lung Cancer Cells Predict Treatment Response?
Synopsis
Key Takeaways
New Delhi, Feb 4 (NationPress) Researchers from Australia have charted the “neighborhoods” of lung cancer cells, revealing that cell metabolism significantly influences how patients react to immunotherapy.
Scientists from the University of Queensland's (UQ) Frazer Institute investigated cell interactions at a cellular level in non-small cell lung carcinoma, the predominant type of lung cancer, to comprehend why certain patients do not respond effectively to immunotherapy, as reported by Xinhua news agency.
Employing machine-learning algorithms and computational methods, the team analyzed how cells interact and metabolize glucose, a vital resource for cancer cells, explained Associate Professor Arutha Kulasinghe of UQ's Frazer Institute.
“By examining the intricate dynamics of cells, we essentially explored the cells’ personal lives within the complex makeup of a tumor, discovering that specific metabolic neighborhoods correlate with responses and resistance to immunotherapy,” Kulasinghe stated.
Given that immunotherapy is expensive and only benefits a small fraction of patients, understanding how to identify suitable candidates, as well as those who may require combination or alternative therapies, is crucial, he added.
Lead author James Monkman from UQ's Frazer Institute noted that higher glucose uptake in cancer cells was linked to less favorable outcomes.
“Cancer cells have a preference for sugar, and we investigated the areas where glucose is processed within the cells and where it is not,” Monkman mentioned.
“It's possible for one region of a tumor to metabolize glucose in a distinctly different manner than another region.”
The research findings have been published in the journal Nature Communications.
The subsequent step involves creating targeted treatments, such as metabolic inhibitors, to enhance the efficacy of immunotherapy, eventually facilitating precision medicine tailored to each patient's tumor, with aspirations to apply this strategy to other cancers, the researchers indicated.